Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.69 +0.10 (+1.32%)
As of: Oct 21, 2026 · 11:36 AM EDT

Eupraxia Pharmaceuticals (EPRX) Debt Ratio (2022 - 2024)

Updated

Eupraxia Pharmaceuticals' Debt Ratio was 0.00 in the quarter ended Jun 30, 2024, down 26.1% from the prior quarter.

Analysis

Eupraxia Pharmaceuticals (EPRX) Debt Ratio (2022 - 2024) Analysis & Trends

From the quarter ended Dec 31, 2022 onward, Eupraxia Pharmaceuticals has reported Debt Ratio for 4 quarters.

  • In earlier years, Debt Ratio was 0.01 in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 0.24
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 0.52
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 0.42
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 0.08
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.28
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 0.53
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 0.31
10 Eupraxia Pharmaceuticals 307.26 Mn -134.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -0.01
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.52
Dec 31, 2022 0.01
API Access

Eupraxia Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=EPRX&period=max&api_key=YOUR_API_KEY